Vet the AI Vendor: A Healthcare Buyer’s Checklist After BigBear.ai’s FedRAMP Play

Hook: Hospitals Need a Better Way to Vet AI — Fast

Healthcare buyers are under pressure: executives want the productivity and diagnostic gains AI promises, clinicians demand safe, explainable tools, and privacy officers need airtight HIPAA controls. The recent late-2025 move by BigBear.ai — eliminating debt while acquiring a FedRAMP-approved AI platform — makes one thing clear: a vendor's government credentials can cut both ways. FedRAMP can be a major plus, but it doesn't eliminate financial, contractual, or government-related risks that matter to hospitals and clinics.

The new procurement reality in 2026

In 2026, healthcare procurement sits at the intersection of two accelerating trends: expanded regulatory scrutiny of AI and a consolidation wave among AI vendors. Late 2025 and early 2026 saw more cloud and AI providers pursue FedRAMP or equivalent third-party attestations, while regulators (national and international) accelerated rule-making — including EU AI Act enforcement timelines and updated U.S. guidance on algorithmic risk management. That means a FedRAMP stamp is now necessary for many use cases, but far from sufficient.

Why FedRAMP matters — and why it isn't the full story

• FedRAMP shows a baseline of cloud security posture — an independent 3PAO assessment, authorization boundary, and ongoing monitoring commitments. For health systems using federal data or partnering with government contractors, FedRAMP helps unblock procurement.
• FedRAMP level matters — Low, Moderate, High: healthcare deployments that handle protected health information (PHI) and mission-critical services usually require at least Moderate, and often High for lifecycle-critical systems.
• FedRAMP does not equal HIPAA compliance. HIPAA is about covered entities, BAAs, and PHI safeguards. A FedRAMP authorization does not remove the need for a signed Business Associate Agreement (BAA) or for HIPAA-specific technical and administrative controls.
• Operational and financial health are separate risks. As illustrated by BigBear.ai’s late-2025 repositioning, debt elimination and FedRAMP acquisition can be positive signals — but falling revenues, contract concentration, or government-dependency exposures can still jeopardize multi-year clinical deployments.

A practical AI vendor due-diligence framework

Below is a concise, actionable checklist tailored for hospitals and clinics evaluating AI vendors in 2026. Use this as a procurement playbook or attach it to your RFP/RFI.

1) Certification & security baseline

• Verify FedRAMP status: confirm authorization level (Low / Moderate / High), effective date, and review the Authorization to Operate (ATO) documentation and Security Package. Ask for the 3PAO report summary and the vendor’s continuous monitoring results.
• Demand HIPAA coverage: require a signed Business Associate Agreement (BAA) with explicit security, breach notification, and indemnity clauses for PHI handling.
• Check other attestations: SOC 2 Type II, ISO 27001, HITRUST CSF, and CSA STAR. Insist on the most recent audit reports and management response to any findings.
• Confirm AI-specific governance: evidence of NIST AI Risk Management Framework adoption, model cards, data sheets for datasets, red-team or adversarial testing, drift detection, and a documented model governance committee.
• Ask for pen-test and vuln management proof points, including remediation SLAs and POA&Ms.

2) Clinical safety and validation

• Request peer-reviewed clinical validation (internal or external) and summary statistics for sensitivity, specificity, PPV/NPV, calibration, and subgroup performance (race, age, comorbidity) — not just aggregate accuracy.
• Require a post-deployment monitoring plan: real-world performance metrics, drift thresholds, and an incident response playbook that includes clinician notification and rollback procedures.
• Insist on human-in-the-loop controls for high-risk decisions and clearly articulated intended use cases, contraindications, and failure modes.

3) Financial stability & business continuity

Financial risk is often the overlooked procurement failure mode: a technically perfect vendor can leave a health system stranded if it fails financially. Include these financial diligence items:

• Review 3 years of audited financial statements (or investor reports for private firms). Watch revenue trajectory, gross margin, and net burn.
• Check customer concentration: ask what percentage of revenue comes from the top 5 customers and top 3 contracts. High concentration increases vendor-specific risk.
• Identify government contract exposure: for vendors with large federal work, ask how dependent they are on a single agency or program. Government funding can be reliable but politically exposed.
• Require KPIs on operational runway and a disclosure of any existing debt covenants or special creditor arrangements — especially after recent refinancing or debt elimination actions like BigBear.ai’s.
• Include contractual guarantees: transition assistance, source-code or model escrow, and defined service termination processes. Consider requiring a vendor-funded transition escrow for mission-critical services.

4) Contract risk & legal protections

• Insist on a right to audit and subcontractor visibility: the vendor must disclose all sub-processors and permit periodic audits of compliance for those third parties.
• Negotiate robust IP and indemnity clauses: define liability for algorithmic errors, data breaches, and regulatory fines. Cap limits should be reasonable and include carve-outs for gross negligence or willful misconduct.
• Define data ownership, portability, and deletion requirements: on contract termination, require return or certified destruction of PHI, and the ability to extract models, weights, or transformation pipelines needed to continue service with a new vendor.
• Include change-of-control clauses: for M&A events (which increase in 2026), require notice periods, reassessment rights, and the option for termination without penalty if the acquirer increases risk profile.
• Embed SLA definitions that reflect clinical priorities: availability, mean time to restore, transaction performance, and time-to-notification for incidents involving PHI or clinical impact.

5) Government and geopolitical risk

In 2026, buyers must explicitly evaluate whether vendors' government relationships or exposures could create risk:

• Assess dependence on federal contracts and possible single-source vulnerability: if a vendor’s business model relies heavily on federal funding, a change in government spending or policy could affect product continuity.
• Check sanctions and export compliance risks: vendors operating across jurisdictions can be constrained by export controls, especially for advanced models or hardware.
• Ask whether the vendor has been subject to government investigations or regulatory action — and request remediation documentation.
• Understand supply chain risk management and how they affect vendors: evidence of supply chain risk management and vendor attestations for critical components should be required.

6) Operational integration & interoperability

• Require technical integration documentation: FHIR APIs, HL7v2 support, mapping guides, and an integration test plan. Confirm whether the vendor supports TEFCA-aligned exchange approaches where relevant.
• Check for vendor lock-in signals: proprietary data formats, closed model runtimes, or lack of export tooling increase long-term costs and switching friction. Consider local inference strategies to avoid black-box runtime lock-in where feasible.
• Ask for evidence of workflow pilot results: clinician adoption rates, time-on-task reduction, and clinical outcomes improvements measured during pilots or early deployments.

Scoring rubric: turn due diligence into a decision

To operationalize vendor selection, use a weighted scorecard. Example weights (adjust by organizational priorities):

• Security & Certifications: 25%
• Clinical Safety & Validation: 20%
• Financial Stability: 20%
• Contractual Protections: 15%
• Operational Integration & Interoperability: 10%
• Government & Geopolitical Risk: 10%

Score each category 1–5 and require a minimum aggregate threshold (for example 75/100) before advancing to legal negotiations or pilots.

Practical contract clauses and language to request

Below are short, high-value contract clauses procurement teams should insist on. These are negotiation starters — involve legal counsel for final language.

• Business Continuity / Transition Assistance: On 90-days written notice of insolvency or contract termination, vendor provides full transition assistance, export of customer data and models, and funding for a certified third-party transition for up to 180 days.
• Source / Model Escrow: Vendor deposits source artifacts, model binaries, and build instructions into a neutral escrow, releasable on defined events (bankruptcy, failure to meet SLAs, change-of-control).
• Right to Audit Subprocessors: Customer has the right to audit any subprocessors handling PHI or model training data, with remediation plans to be provided within 30 days.
• BAA and PHI Remedies: Vendor accepts HIPAA obligations as a Business Associate and agrees to indemnify the covered entity for breaches resulting from vendor’s failure to safeguard PHI.
• Regulatory Change Clause: If future regulatory changes (U.S. or EU) make the product non-compliant, vendor must provide a remediation plan and timeline; failure allows termination without penalty.

Monitoring the vendor post-contract: continuous oversight

Procurement doesn't end at signature. Create a vendor governance cadence across security, clinical, legal, and finance functions:

• Quarterly security reviews and access to continuous monitoring dashboards (SOC2, FedRAMP POA&M updates).
• Monthly clinical performance reports with subgroup analyses and explanation of any drift or retraining events.
• Annual financial health review and notification obligations for material financial events (e.g., bankruptcy filings, major revenue loss, or change of control).
• Incident playbook rehearsals with tabletop exercises for clinical downtime and data incidents.

Case: Applying the framework to a BigBear.ai–style scenario

Consider a mid-sized health system evaluating an AI vendor that, like BigBear.ai in late 2025, has just acquired a FedRAMP-authorized AI platform and reported corporate restructuring:

1. Start with certification verification: confirm the acquired platform’s FedRAMP authorization boundary actually covers the healthcare data and use-case you plan to deploy.
2. Ask for a detailed mapping between FedRAMP controls and HIPAA controls, and require a signed BAA covering the platform and any newly merged entities.
3. Perform financial diligence focused on revenue sources: if a large percentage of the vendor’s revenue is from a single federal customer, demand stronger transition guarantees and escrow protections.
4. Review the vendor’s post-merger integration plan and staffing stability for product teams that support your deployment. High churn in engineering or product teams is a real red flag; check platform and ops playbooks used for integrations (platform ops).
5. Negotiate a shorter initial contract term with renewal contingent on demonstrated post-deployment stability and audit outcomes.

Key lesson: A FedRAMP acquisition can make a vendor eligible for more contracts — but it does not replace clinical validation, financial due diligence, or robust contracting.

2026 trends that hospital buyers must watch

• Mandatory AI conformity assessment regimes: The EU AI Act and nascent U.S. rulemaking are increasing requirements for high-risk clinical AI systems. Vendors will increasingly need third-party conformity assessments.
• Model transparency standards: Expect more standardized model documentation (model cards, training data lineage, and provenance) to become procurement must-haves.
• Greater emphasis on equity testing: Regulators and payors are requiring bias audits and subgroup performance reports before approving clinical decision-support AI for broad deployment.
• Integration-first procurement: Hospitals will favor vendors with documented FHIR-based interoperability and plug-and-play integration kits, reducing delayed go-lives and hidden costs.

Checklist: 10 must-ask questions for any AI vendor

1. What is your current FedRAMP authorization level and can you provide the ATO package and 3PAO summary?
2. Will you sign a BAA and demonstrate how FedRAMP controls map to HIPAA safeguards?
3. Can you provide peer-reviewed clinical validation and subgroup performance metrics?
4. What percent of your revenue is from your top five customers, and what is your operational runway?
5. Do you hold SOC2, ISO 27001, or HITRUST certifications? Provide recent reports and management responses.
6. Who are your subprocessors and where is customer data stored and processed (regions)?
7. Do you provide source/model escrow and what triggers release?
8. What are your incident response SLAs and breach notification timelines?
9. How do you monitor model drift and what is your retraining governance?
10. What contractual transition assistance and termination rights do you offer in case of insolvency or change-of-control?

Actionable next steps for procurement teams

1. Adopt the scorecard above and require vendors to submit answers as part of your RFI. Score objectively, and don’t skip financial diligence.
2. Make legal, InfoSec, and clinical leadership co-owners of the evaluation process; require consensus before pilot funding.
3. For pilots, set clear success criteria linked to clinical metrics, security posture, and integration timelines; include a short-term contract with exit and transition protections.
4. Invest in continuous monitoring tooling and budget for third-party audits at contract renewal milestones. Consider edge storage and local sync approaches as part of resilience planning.

Final takeaways

BigBear.ai’s late-2025 play — debt elimination plus acquiring a FedRAMP-enabled AI stack — is emblematic of 2026’s procurement environment: vendors are chasing certifications and deals quickly, sometimes as part of financial restructuring. For hospitals and clinics, the right response is a disciplined, cross-functional due-diligence process that views FedRAMP as a critical trust signal but not the final word.

Bottom line: Require certifications, validate clinical safety, protect against vendor financial failure, and build robust contract mechanisms for continuity and auditability.

Call to action

Ready to operationalize this framework? Download our customizable AI Vendor Scorecard and contract clause templates, or schedule a 30-minute advisory call with our health IT governance experts to map the checklist to your next RFP. Safeguard your patients and your organization — start your vendor risk review today.

Related Reading

• Audit-Ready Text Pipelines: Provenance, Normalization and LLM Workflows for 2026
• Run Local LLMs on a Raspberry Pi 5: Building a Pocket Inference Node for Scraping Workflows
• Edge Storage for Small SaaS in 2026: Choosing CDNs, Local Testbeds & Privacy-Friendly Analytics
• Cashtags for Musicians: Monitoring Music Industry Stocks and Trends on Bluesky
• Community Migration Playbook: Moving Audiences from X to Bluesky, Digg or New Platforms
• Pre‑Show Rituals for Performers: A Yoga Sequence for Touring Musicians
• How EU Ad Regulation Moves Could Change Survey Recruitment and Targeting
• Best 3-in-1 Wireless Chargers Under $100 (And When to Buy)